Cargando…
Cannabis-Based Products in a Neurological Setting: A Clinical and Pharmacokinetic Survey
BACKGROUND AND AIM: Limited data are available in clinical settings on the pharmacokinetics of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). We investigated the use of cannabis-based products in neurological practice, monitoring patients' steady-state cannabinoids (CBs) plasma conce...
Autores principales: | Mohamed, Susan, Lopane, Giovanna, Sabattini, Loredana, Scandellari, Cinzia, Zardi, Diletta, Donadio, Vincenzo, Rizzo, Giovanni, Perrone, Alessandro, Lugaresi, Alessandra, Contin, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997238/ https://www.ncbi.nlm.nih.gov/pubmed/35418935 http://dx.doi.org/10.3389/fneur.2022.784748 |
Ejemplares similares
-
When ‘good’ is not good enough: a retrospective Rasch analysis study of the Berg Balance Scale for persons with Multiple Sclerosis
por: Caselli, Serena, et al.
Publicado: (2023) -
Sex Is the Main Determinant of Levodopa Clinical Pharmacokinetics: Evidence from a Large Series of Levodopa Therapeutic Monitoring
por: Contin, Manuela, et al.
Publicado: (2022) -
Inflammatory optic neuropathy following SARS-CoV-2 mRNA vaccine: Description of two cases
por: Barone, Valentina, et al.
Publicado: (2021) -
Case report: Bilateral double beta peak activity is influenced by stimulation, levodopa concentrations, and motor tasks, in a Parkinson’s disease patient on chronic deep brain stimulation
por: Giannini, Giulia, et al.
Publicado: (2023) -
A Rapid and Simple UHPLC-MS/MS Method for Quantification of Plasma Globotriaosylsphingosine (lyso-Gb3)
por: Perrone, Alessandro, et al.
Publicado: (2021)